510(k) K201689
K201689 is an FDA 510(k) premarket notification submitted by Micro Therapeutics, Inc. D/B/A Ev3 Neurovascular for the device "Riptide Aspiration System". The FDA issued a decision of Substantially Equivalent on Jul 21, 2020. The device falls under product code NRY (Catheter, Thrombus Retriever), a Class II device regulated under 21 CFR 870.1250. Micro Therapeutics, Inc. D/B/A Ev3 Neurovascular has 31 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 21, 2020
- Date Received
- Jun 22, 2020
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Catheter, Thrombus Retriever
- Device Class
- Class II
- Regulation Number
- 870.1250
- Review Panel
- NE
- Submission Type
- 510(k)
The device is intended to restore blood flow by removing thrombus/clots in patients experiencing ischemic stroke. The prior clearances in this category have been limited to simply identifying catheter placed in the peripheral, coronary, and neurovasculature. It is felt that this is a unique claim and should not be combined with previously cleared catheters under a general procode.
Need the full FDA record for Micro Therapeutics, Inc. D/B/A Ev3 Neurovascular? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.